Proline.

Prolyl hydroxylase needs ascorbate to stay reduced while it converts proline residues into hydroxyproline. Without adequate ascorbate the collagen triple helix does not assemble normally.

Collagen repeats a glycine-X-Y motif in which proline and lysine occupy the X and Y positions. Supplying both amino acids covers the two residues collagen needs in the largest amounts after glycine.

Every third residue of the collagen helix is glycine, and the adjacent position is most often proline. The two are the dominant residues in the collagen sequence.

Hydroxyproline is made from proline residues already built into the collagen chain by prolyl hydroxylase. The two sit on either side of a single enzymatic step.

Prolyl hydroxylase is an iron-dependent dioxygenase that holds Fe(II) at its active site. Iron status therefore sets the ceiling on how fast proline is hydroxylated.

Once proline-rich chains have assembled, the copper-dependent enzyme lysyl oxidase forms the crosslinks that stabilise the fibril. Proline supplies the chain and copper supports the step that locks it together.

Ornithine and proline interconvert through the shared intermediate pyrroline-5-carboxylate. Either one can feed the pool the other draws on.

Arginine is hydrolysed to ornithine, which passes through pyrroline-5-carboxylate to proline. This is the main route by which dietary arginine contributes to proline supply.

Glutamine is deamidated to glutamate, which is reduced to pyrroline-5-carboxylate and then to proline. Glutamine is the usual upstream source of the proline carbon skeleton.

Glutamate is reduced by P5C synthase and P5C reductase to give proline. It is the immediate precursor in the biosynthetic route.

Collagen peptides deliver proline and hydroxyproline as di- and tripeptides, and added free proline widens the amino acid pool available for new chain synthesis. The two are routinely formulated together for that reason.

Histidine and proline were tested together as a defined pair in muscle cells, where the authors report shifts in oxidative and mitochondrial measures. Both amino acids feed carbon into intermediary metabolism rather than acting on one shared enzyme. The finding sits at the cell level, so it describes a mechanism rather than a measured effect in people. Read it as mechanistic support for co-formulating the two.

Proline can be built from ornithine as well as from glutamate. The ornithine route runs through ornithine aminotransferase, which carries pyridoxal-5-phosphate, the active form of vitamin B6, as its cofactor. Without adequate B6 status that arm of proline supply slows. This is settled cofactor biochemistry rather than a tested supplement combination.

When proline is oxidised back toward glutamate, proline dehydrogenase passes electrons through a bound flavin cofactor into the mitochondrial electron transport chain. That flavin comes from dietary riboflavin. The relationship is textbook cofactor chemistry, so it holds without a combination trial. It describes proline turnover, not a claim about any measured outcome.

The final step of proline synthesis reduces pyrroline-5-carboxylate using NAD(P)H, and the proline cycle regenerates oxidised cofactor for other reactions. The cofactor dependence itself is established biochemistry. Whether supplemental NAD precursors change proline handling in people has not been shown, so the pairing is mechanistic. State it as shared cofactor traffic rather than an additive effect.

Most recycled proline arrives as X-proline dipeptides from collagen breakdown, and only prolidase can split that bond. Prolidase carries manganese at its active site. Adequate manganese status therefore sits upstream of proline recycling. This is established enzymology and needs no combination study.

Citrulline is converted to arginine in the kidney, arginase then yields ornithine, and ornithine aminotransferase carries ornithine toward pyrroline-5-carboxylate and on to proline. Each step is a mapped enzymatic route rather than an inference. The size of any shift in tissue proline from supplemental citrulline has not been quantified in people. The pairing is a precursor relationship, not an additive effect.

Prolyl-4-hydroxylase is a 2-oxoglutarate dependent dioxygenase, so every proline residue it hydroxylates consumes one molecule of alpha-ketoglutarate. Alpha-ketoglutarate also transaminates to glutamate, the starting point of de novo proline synthesis. Both links are settled biochemistry. The row describes substrate supply and not a demonstrated clinical effect.

Reducing pyrroline-5-carboxylate to proline consumes NADPH, and so does regenerating reduced glutathione from its oxidised form. The proline cycle is one of the routes that hands NADP back to the pentose phosphate pathway. This is a shared cofactor economy rather than a demonstrated interaction in people. Regard it as mechanistic context for pairing the two.

Silicon and proline appear together in connective-tissue blends because each is linked to normal collagen matrix formation from a different angle. The silicon literature is largely observational and mechanistic, so the pairing rests on association rather than a measured combined effect. No trial has tested the two together. The row is formulation logic labelled as such.

Hyaluronic acid and proline occupy different parts of the extracellular matrix story: one is a glycosaminoglycan that holds water, the other a residue built into the collagen triple helix. Products combine them for that complementarity. Nothing has tested the pair head to head. This is formulation practice, stated at its true confidence.